Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-09

Clinical Trial Update: Fenfluramine for Adult Dravet Patients [Phase 3]

View source ↗

Summary

Trial update for fenfluramine in adult Dravet patients is in Phase 3 with unclear status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fenfluramine (fenfluramine)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Dravet Syndrome, Dravet Syndrome, Intractable | Phase 3 | Status: UNKNOWN